Reporter Staff

Reporter Staff

| This email address is being protected from spambots. You need JavaScript enabled to view it.

Eligible employees in workgroup A will complete self-evaluations in the Performance App. Managers must have conversations with employees and complete evaluations by Sept. 30. Check your workgroup here and visit the Performance Management site for tools, FAQs and training.

The Critical Support site at go.uab.edu/criticalsupport walks users through a six-step process they can follow in high stress situations to help ensure a safe and successful outcome for all involved — and each step includes additional guidance and support tools.

We are looking for transgender men and non-binary people who are at least 18 years old interested in starting testosterone therapy to participate in a sexual health research study. Call the UAB Sexual Health Research Clinic at 205-934-8166. Compensation provided.
Help us find out by joining our study at UAB You may be eligible to participate in the PRECISION-BP research study investigating the effects of Sacubitril/Valsartan or Valsartan on your body’s 24-hour rhythm of a hormone in your blood called natriuretic peptides. This hormone and the study medications are related to the heart. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Nehal at PRECISION-BPSTUDY@uabmc.edu or call us at 205-934-7173 if you are interested

Jie Gao, Camerron Crowder, Ken Marion and James B. McClintock demonstrated extraordinary commitment to engaging undergraduate students in service learning, undergraduate research and education-abroad experiences.

We are actively recruiting for research studies focused on women with one of the following conditions:

1. Accidental bowel leakage (fecal incontinence)
2. Urinary leakage (urinary incontinence)

Please call 205-934-5498 to learn more about these studies.
If you are currently pregnant, 18 or older, planning to deliver at UAB, and planning to breast feed, you may be eligible for our study!

This study focuses on better understanding breast milk composition, the presence or absence of CMV in breast milk, and its possible transmission to babies. CMV is a common virus that most people in the US are infected with by adulthood. Participants will meet with study staff once a month for six months to collect non-invasive samples and answer a questionnaire. Samples collected include oral swabs from you and your baby, a small quantity of breast milk and a skin swab from you, as well as a urine and stool sample from your baby. Participants will be compensated up to $300 for completing the study visits and providing samples. Eligible participants may also qualify for additional sub-studies for additional compensation up to $800.

For more information, please contact us via phone or email at:
Phone: 205-975-3752
Email: milk@uabmc.edu
BrainREAD is recruiting children with autism and typically-developing children, ages 7-13, who have reading comprehension difficulties to participate in an MRI study that includes a free reading intervention through Lindamood-Bell Learning Processes. Participation involves two sessions each of which are broken up into two days - one day of neuropsych assessments and one day for the scan. Participants can be compensated up to $125 for the first scan and tests with an additional $125 for the follow-up scan and tests, 12 weeks later. If interested, please call 205-202-0616, email cbralab@ua.edu or visit cbra.ua.edu/brainread.html and fill out our contact form.
If you’re being treated for MDD and your current antidepressant medication(s) is not working, the SAVITRI Study might interest you. The SAVITRI Study is researching a potential MDD therapy to improve symptoms of depression, and you may be able to participate. This research study is now enrolling adults diagnosed with MDD. Those who qualify will receive the investigational medication (or placebo), study-specific medical exams, and study-specific laboratory tests at no cost. Participants in the SAVITRI Study must: be 18 to 65 years of age; have a clinical diagnosis of MDD; be currently on antidepressant medication(s); have had inadequate response to up to 5 oral antidepressant medications; and fulfill other eligibility criteria. For more information, please call (205) 996-5987 or email lalexander@uabmc.edu. Please mention SAVITRI in your message.
Do you have a loved one with agitation associated with Alzheimer’s dementia? Is their agitation becoming overwhelming? Examples of some easily identifiable agitated behaviors are: restlessness, screaming, shouting, throwing things, resistiveness, constant unwarranted requests for attention or help, pacing/aimless wandering, kicking, hitting others or self, pushing people, hurting self or others, tearing things or destroying property. In this study, researchers want to find out if an investigational drug called AVP-786 is safe and effective (useful) in managing agitation in adults with Alzheimer’s dementia, when compared to a placebo. If you are a caregiver for a person with Alzheimer’s disease, please call (205) 996-5987 or email lalexander@uabmc.edu for more information.
Page 9 of 64